Showing 1 - 12 results of 12 for search 'Peter T. Yu', query time: 0.04s Refine Results
  1. 1
    Customizing Fair Use Transplants

    Customizing Fair Use Transplants by Peter K. Yu

    Published 2018-02-01
    Get full text
    Article
  2. 2
    UNIVERSITY STUDENTS’ SLANG AND ITS USING CONTEXT IN TAIWAN: COMPLIMENTING AND REBUKING DICTIONS AS EXAMPLES

    UNIVERSITY STUDENTS’ SLANG AND ITS USING CONTEXT IN TAIWAN: COMPLIMENTING AND REBUKING DICTIONS AS EXAMPLES by PETER CHIEN-YU, KAO

    Published 2014-05-01
    Get full text
    Article
  3. 3
    Fluid effects in vibrating micromachined structure

    Fluid effects in vibrating micromachined structure by Kwok, Peter (Peter Yu), 1975-

    Published 2005
    Get full text
    Thesis
  4. 4
    Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer

    Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer by Peter Paul Yu, Omar Eton, Louis P. Garrison

    Published 2019-09-01
    Get full text
    Article
  5. 5
    Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2

    Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2 by Priya Londhe, Priya Londhe, Peter Y. Yu, Peter Y. Yu, Yuichi Ijiri, Yuichi Ijiri, Katherine J. Ladner, Katherine J. Ladner, Joelle M. Fenger, Cheryl London, Cheryl London, Peter J. Houghton, Denis C. Guttridge, Denis C. Guttridge

    Published 2018-04-01
    Get full text
    Article
  6. 6
    MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.

    MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines. by Cecilia M Lopez, Peter Y Yu, Xiaoli Zhang, Ayse Selen Yilmaz, Cheryl A London, Joelle M Fenger

    Published 2018-01-01
    Get full text
    Article
  7. 7
    Management of choledocholithiasis in an infant

    Management of choledocholithiasis in an infant by Peter T. Yu, Stephen J. Fenton, Patrick T. Delaplain, Jesse Vrecenak, N. Scott Adzick, Michael L. Nance, Yigit S. Guner

    Published 2018-02-01
    Get full text
    Article
  8. 8
    Rapid Prototyping of Polymer-Based Rolled-Up Microfluidic Devices

    Rapid Prototyping of Polymer-Based Rolled-Up Microfluidic Devices by Rerngchai Arayanarakool, Hian Hian See, Samuel David Marshall, Niven Singh Virik, Heng Wang, Poh Seng Lee, Peter Chao Yu Chen

    Published 2018-10-01
    Get full text
    Article
  9. 9
    Impact of Merit-Based Immigration Policies on Brain Drain From Low- and Middle-Income Countries

    Impact of Merit-Based Immigration Policies on Brain Drain From Low- and Middle-Income Countries by Nagi S. El Saghir, Benjamin O. Anderson, Julie Gralow, Gilberto Lopes, Lawrence N. Shulman, Hiba A. Moukadem, Peter Paul Yu, Gabriel Hortobagyi

    Published 2020-11-01
    Get full text
    Article
  10. 10
    The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting

    The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting by Howard L. Kaufman, Michael B. Atkins, Adam P. Dicker, Heather S. Jim, Louis P. Garrison, Roy S. Herbst, William T. McGivney, Steven Silverstein, Jon M. Wigginton, Peter P. Yu

    Published 2017-04-01
    Get full text
    Article
  11. 11
    miR-133a function in the pathogenesis of dedifferentiated liposarcoma

    miR-133a function in the pathogenesis of dedifferentiated liposarcoma by Peter Y. Yu, Gonzalo Lopez, Danielle Braggio, David Koller, Kate Lynn J. Bill, Bethany C. Prudner, Abbie Zewdu, James L. Chen, O. Hans Iwenofu, Dina Lev, Anne M. Strohecker, Joelle M. Fenger, Raphael E. Pollock, Denis C. Guttridge

    Published 2018-06-01
    Get full text
    Article
  12. 12
    Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.

    Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. by Peter Y Yu, Heather L Gardner, Ryan Roberts, Hakan Cam, Seethalakshmi Hariharan, Ling Ren, Amy K LeBlanc, Hui Xiao, Jiayuh Lin, Denis C Guttridge, Xiaokui Mo, Chad E Bennett, Christopher C Coss, Yonghua Ling, Mitch A Phelps, Peter Houghton, Cheryl A London

    Published 2017-01-01
    Get full text
    Article

Search Tools: